WallStreetZenWallStreetZen

NASDAQ: PYXS
Pyxis Oncology Inc Stock

$2.21+0.28 (+14.51%)
Updated Mar 24, 2023
PYXS Price
$2.21
Fair Value Price
N/A
Market Cap
$81.73M
52 Week Low
$1.10
52 Week High
$5.00
P/E
-0.61x
P/B
0.51x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$120.72M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.31
Operating Cash Flow
-$89M
Beta
0.68
Next Earnings
Mar 28, 2023
Ex-Dividend
N/A
Next Dividend
N/A

PYXS Overview

Pyxis Oncology, Inc. is a preclinical stage biopharmaceutical company developing cancers therapies. Its product candidate, PYX-106, targets thyroid cancer, head and neck squamous cell carcinoma, non-small cell lung cancer (NSCLC), and other solid tumors. PYX-102 is an investigational immune-therapeutic for treatment of solid tumors. Pyxis Oncology was incorporated in 2018 and is headquartered in Cambridge, MA.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PYXS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PYXS is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PYXS is good value based on its book value relative to its share price (0.51x), compared to the US Biotechnology industry average (4.89x)
P/B vs Industry Valuation
PYXS is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more PYXS due diligence checks available for Premium users.

Be the first to know about important PYXS news, forecast changes, insider trades & much more!

PYXS News

Valuation

PYXS fair value

Fair Value of PYXS stock based on Discounted Cash Flow (DCF)
Price
$2.21
Fair Value
$7.54
Undervalued by
70.68%
PYXS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

PYXS price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.61x
Industry
17.88x
Market
21.37x

PYXS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.51x
Industry
4.89x
PYXS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

PYXS's financial health

Profit margin

Revenue
$0.0
Net Income
-$36.1M
Profit Margin
0%
PYXS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$211.4M
Liabilities
$50.6M
Debt to equity
0.31
PYXS's short-term assets ($186.61M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PYXS's short-term assets ($186.61M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PYXS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$17.4M
Investing
-$1.9M
Financing
$0.0
PYXS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

PYXS vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
PYXS$81.73M+14.51%-0.61x0.51x
FBIO$81.90M+0.94%-0.29x1.33x
VTVT$82.83M+1.67%-3.05x-7.71x
IFRX$80.47M-3.38%-2.52x0.86x
RVPH$80.34M-0.51%-3.61x3.95x

Pyxis Oncology Stock FAQ

What is Pyxis Oncology's quote symbol?

NASDAQ: PYXS) Pyxis Oncology trades on the NASDAQ under the ticker symbol PYXS. Pyxis Oncology stock quotes can also be displayed as NASDAQ: PYXS.

If you're new to stock investing, here's how to buy Pyxis Oncology stock.

What is the 52 week high and low for Pyxis Oncology (NASDAQ: PYXS)?

(NASDAQ: PYXS) Pyxis Oncology's 52-week high was $5.00, and its 52-week low was $1.10. It is currently -55.8% from its 52-week high and 100.91% from its 52-week low.

How much is Pyxis Oncology stock worth today?

(NASDAQ: PYXS) Pyxis Oncology currently has 36,980,621 outstanding shares. With Pyxis Oncology stock trading at $2.21 per share, the total value of Pyxis Oncology stock (market capitalization) is $81.73M.

Pyxis Oncology stock was originally listed at a price of $13.20 in Oct 8, 2021. If you had invested in Pyxis Oncology stock at $13.20, your return over the last 1 years would have been -83.26%, for an annualized return of -83.26% (not including any dividends or dividend reinvestments).

How much is Pyxis Oncology's stock price per share?

(NASDAQ: PYXS) Pyxis Oncology stock price per share is $2.21 today (as of Mar 24, 2023).

What is Pyxis Oncology's Market Cap?

(NASDAQ: PYXS) Pyxis Oncology's market cap is $81.73M, as of Mar 27, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Pyxis Oncology's market cap is calculated by multiplying PYXS's current stock price of $2.21 by PYXS's total outstanding shares of 36,980,621.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.